{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:47:18Z","timestamp":1779184038591,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T00:00:00Z","timestamp":1322092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s11764-010-0164-4","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T09:59:10Z","timestamp":1322128750000},"page":"102-114","source":"Crossref","is-referenced-by-count":18,"title":["Polymorphisms in immune function genes and non-Hodgkin lymphoma survival"],"prefix":"10.1007","volume":"6","author":[{"given":"Briseis","family":"Aschebrook-Kilfoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongzhang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangge","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuesong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore","family":"Holford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingtai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Leaderer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Rothman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,24]]},"reference":[{"key":"164_CR1","unstructured":"Clarke C, O\u2019Malley C. Chapter 28 Non-Hodgkin lymphoma. In: Ries LAG, Yong JL, Keel GE, Eisner MP, Lin YD, Horner M-JD [eds] Cancer survival among adults: U.S. SEER Program, 1988\u20132001, patient and tumor characteristics. National Cancer Institutes, SEER Program, NIH, Bethsda, pp 235\u201342, 2007."},{"issue":"8","key":"164_CR2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10552-008-9147-4","volume":"19","author":"X Han","year":"2008","unstructured":"Han X, Kilfoy B, Zheng T, Holford TR, Zhu C, Zhu Y, et al. Lymphoma survival patterns by WHO subtype in the United States, 1973\u20132003. Cancer Causes Control. 2008;19(8):841\u201358. Epub 2008 Mar 26.","journal-title":"Cancer Causes Control"},{"issue":"15","key":"164_CR3","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","volume":"92","author":"FD Groves","year":"2000","unstructured":"Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst. 2000;92(15):1240\u201351.","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"164_CR4","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329(14):987\u201394.","journal-title":"N Engl J Med"},{"key":"164_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A. Inflammation and cancer: Back to Virchow? Lancet. 2001;357:539\u201345.","journal-title":"Lancet"},{"issue":"7","key":"164_CR6","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/cncr.10403","volume":"94","author":"CA Clarke","year":"2002","unstructured":"Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer. 2002;94(7):2015\u201323.","journal-title":"Cancer"},{"key":"164_CR7","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1182\/blood-2005-10-4160","volume":"107","author":"Q Lan","year":"2006","unstructured":"Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1\/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood. 2006;107:4101\u20138.","journal-title":"Blood"},{"issue":"11","key":"164_CR8","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.bjc.6601388","volume":"89","author":"LM Morton","year":"2003","unstructured":"Morton LM, Holford TR, Leaderer B, Boyle P, Zahm SH, Zhang Y, et al. Cigarette smoking and risk of non-Hodgkin lymphoma subtypes among women. Br J Cancer. 2003;89(11):2087\u201392.","journal-title":"Br J Cancer"},{"issue":"4","key":"164_CR9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/B:CACO.0000027506.55846.5d","volume":"15","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Holford TR, Leaderer B, Zahm SH, Boyle P, Morton LM, et al. Prior medical conditions and medication use and risk of non-Hodgkin lymphoma in Connecticut United States women. Cancer Causes Control. 2004;15(4):419\u201328.","journal-title":"Cancer Causes Control"},{"key":"164_CR10","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 1997;89:3909\u201318.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"164_CR11","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835\u201349.","journal-title":"J Clin Oncol"},{"key":"164_CR12","doi-asserted-by":"crossref","first-page":"D617","DOI":"10.1093\/nar\/gkj151","volume":"34","author":"BR Packer","year":"2006","unstructured":"Packer BR, Yeager M, Burdett L, Welch R, Beerman M, Qi L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res. 2006;34:D617\u201321.","journal-title":"Nucleic Acids Res"},{"key":"164_CR13","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/381000","volume":"74","author":"CS Carlson","year":"2004","unstructured":"Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet. 2004;74:106\u201320.","journal-title":"Am J Hum Genet"},{"key":"164_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.172.1.61","volume":"172","author":"G Scala","year":"1990","unstructured":"Scala G, Quinto I, Ruocco MR, Arcucci A, Mallardo M, Caretto P, et al. Expression of an exogenous interleukin-6 gene in human Epstein Barr virus B-cells confers growth advantage and tumorigenicity. J Exp Med. 1990;172:61\u20138.","journal-title":"J Exp Med"},{"issue":"1","key":"164_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejvs.2007.08.021","volume":"35","author":"L Smallwood","year":"2008","unstructured":"Smallwood L, Allcock R, van Bockxmeer F, Warrington N, Palmer LJ, Iacopetta B, et al. Polymorphisms of the interleukin-6 gene promoter and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2008;35(1):31\u20136. Epub 2007 Nov 8.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"164_CR16","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1182\/blood.V74.2.798.798","volume":"74","author":"C-Y Yee","year":"1989","unstructured":"Yee C-Y, Biondi A, Wang X-H, Iscove NN, de Sousa J, Aarden LA, et al. A possible autocrine role for interleukin-6 in two lymphoma cell lines. Blood. 1989;74:798\u2013804.","journal-title":"Blood"},{"key":"164_CR17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0344-0338(11)80112-3","volume":"189","author":"M Takeshita","year":"1993","unstructured":"Takeshita M, Sumiyoshi Y, Masuda Y, Ohshima K, Yoshida T, Kikuchi M, et al. Cytokine[interleukin- la, interleukin- Ip, tumor necrosis factor a, andinterleukin-6]-possessing cells in lymph nodes of malignant lymphoma. Pathol Res Pract. 1993;189:18\u201325.","journal-title":"Pathol Res Pract"},{"key":"164_CR18","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1172\/JCI114046","volume":"83","author":"GJ Freeman","year":"1989","unstructured":"Freeman GJ, Freedman AS, Rabinowe SN, Segil JM, Horowitz J, Rosen K, et al. Interleukin 6 gene expression in normal and neoplastic B-cells. J Clin Invest. 1989;83:1512\u20138.","journal-title":"J Clin Invest"},{"key":"164_CR19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/blood.V80.2.498.498","volume":"80","author":"D Emilie","year":"1992","unstructured":"Emilie D, Coumbaras J, Raphael M, Devergne O, Delecluse HJ, Gisselbrecht C, et al. Interleukin-6 production in high-grade B-lymphomas: correlation with the presence of malignant imniunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood. 1992;80:498\u2013504.","journal-title":"Blood"},{"key":"164_CR20","doi-asserted-by":"crossref","first-page":"008","DOI":"10.1172\/JCI114392","volume":"84","author":"R Bataille","year":"1989","unstructured":"Bataille R, Jourdan M, Zhang X-G, Klein B. Serum levels of interleukin 6. a potent myeloma cell growth factor, as a reflection of disease severity in plasma cell dyscrasias. J Clin Invest. 1989;84:008\u201311.","journal-title":"J Clin Invest"},{"key":"164_CR21","first-page":"45e49","volume":"60","author":"GS Chopra","year":"2004","unstructured":"Chopra GS, Chitalkar PG, Jaiprakash MP. Cytokines: as useful prognostic marker in lymphoma cases. MJAFI. 2004;60:45e49.","journal-title":"MJAFI"},{"issue":"12","key":"164_CR22","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1182\/blood-2006-11-058040","volume":"109","author":"JR Cerhan","year":"2007","unstructured":"Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, et al. Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood. 2007;109(12):5439\u201346. Epub 2007 Feb 27.","journal-title":"Blood"},{"key":"164_CR23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02361238","volume":"29","author":"T Ueda","year":"1994","unstructured":"Ueda T, Shimada E, Urakawa T. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol. 1994;29:423\u20139.","journal-title":"J Gastroenterol"},{"key":"164_CR24","first-page":"93","volume":"152","author":"Y Kitadai","year":"1998","unstructured":"Kitadai Y, Haruma K, Sumii K, et al. Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol. 1998;152:93\u2013100.","journal-title":"Am J Pathol"},{"key":"164_CR25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<546::AID-PATH487>3.0.CO;2-L","volume":"189","author":"W Nurnberg","year":"1999","unstructured":"Nurnberg W, Tobias D, Otto F, Henz BM, Schadendorf D. Expression of interleukin-8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma. J Pathol. 1999;189:546\u201351.","journal-title":"J Pathol"},{"key":"164_CR26","first-page":"208","volume":"84","author":"S Molica","year":"1999","unstructured":"Molica S, Vitelli G, Levato D, Levato L, Dattilo A, Gandolfo GM. Clinicobiological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia. Haematologica. 1999;84:208\u201311.","journal-title":"Haematologica"},{"key":"164_CR27","unstructured":"SEER Limited-Use 1973-2004\u2014ASCII Text Data: Surveillance, Epidemiology, and End Results [SEER] Program [ www.seer.cancer.gov ] Limited-Use Data [1973\u20132004], National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission."},{"key":"164_CR28","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1056\/NEJMp048257","volume":"351","author":"R Kuppers","year":"2004","unstructured":"Kuppers R. Prognosis in follicular lymphoma\u2014it\u2019s in the microenvironment. N Engl J Med. 2004;351:2152\u20133.","journal-title":"N Engl J Med"},{"key":"164_CR29","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1158\/0008-5472.CAN-05-3705","volume":"66","author":"KW Hunter","year":"2006","unstructured":"Hunter KW, Crawford NP. Germ line polymorphism in metastatic progression. Cancer Res. 2006;66:1251\u20134.","journal-title":"Cancer Res"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-010-0164-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11764-010-0164-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-010-0164-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T23:46:05Z","timestamp":1593301565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11764-010-0164-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,24]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["164"],"URL":"https:\/\/doi.org\/10.1007\/s11764-010-0164-4","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,24]]}}}